Tevogen Bio doubles HQ leased space to 13,242 RSF; lease extended to Feb 2033

Tevogen Bio Holdings Inc.

Lease amendment doubles space from 6,708 to 13,242 rentable square feet on Building's 2nd floor.
Term extended seven years to February 28, 2033; annual base rent approx. $330,000 ($24.75/RSF).
Relocation from 4th floor to 2nd floor effective June 1, 2025; prior lease terminated.
Employees from Philadelphia R&D center to be relocated after its lease expires June 2025.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.